Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Common Equity: 2019-2025

Historic Common Equity for P3 Health Partners (PIII) over the last 7 years, with Q3 2025 value amounting to -$18.7 million.

  • P3 Health Partners' Common Equity fell 11550.53% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.7 million, marking a year-over-year decrease of 11550.53%. This contributed to the annual value of $75.9 million for FY2024, which is 4657.29% down from last year.
  • As of Q3 2025, P3 Health Partners' Common Equity stood at -$18.7 million, which was down 11550.53% from $44.5 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Common Equity high stood at $263.0 million for Q1 2022, and its period low was -$272.9 million during Q4 2021.
  • Over the past 5 years, P3 Health Partners' median Common Equity value was $63.2 million (recorded in 2025), while the average stood at $22.1 million.
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 22535.48% in 2023, then surged by 555981.38% in 2024.
  • P3 Health Partners' Common Equity (Quarter) stood at -$272.9 million in 2021, then skyrocketed by 102.14% to $5.9 million in 2022, then soared by 2327.91% to $142.1 million in 2023, then crashed by 46.57% to $75.9 million in 2024, then tumbled by 124.61% to -$18.7 million in 2025.
  • Its last three reported values are -$18.7 million in Q3 2025, $44.5 million for Q2 2025, and $63.2 million during Q1 2025.